Last 12 months
Inside the activity.
8 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 8 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2023 Filed Sep 19, 2023 20:48 UTC |
DIAS FIONA PDirector
|
GrantDividend Equivalent Rights - QRTEA · Derivative | 864 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-008998 · doc4.xml · derivative · entry 1 DIAS FIONA P · CIK 0001209881 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,644 Underlying: Series A Common Stock · 864 shares Expires not disclosed F1 · derivative.exercise_price: On August 16, 2023, the Issuer announced that an authorized committee of its board of directors declared a quarterly cash dividend in the amount of $2.00 per share of its 8.0% Series A Cumulative Redeemable Preferred Stock ("Preferred Stock") payable on September 15, 2023 to stockholders of record of the Preferred Stock at the close of business on August 31, 2023 (the "Dividend"). The equivalent rights accrued on restricted stock units with respect to the Issuer's Preferred Stock ("Original RSUs") held by the reporting person as a result of the Dividend and are subject to the same terms and conditions (including vesting and expiration) as the Original RSUs to which they relate. Each dividend equivalent right entitles the reporting person to receive one share of the Issuer's Series A Common Stock. The grant of dividend equivalent rights was approved by the Issuer's board of directors pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: Each dividend equivalent right vests upon the reporting person's termination of service to the Issuer's board of directors. F3 · derivative.expiration_date: Each dividend equivalent right expires upon the reporting person's termination of service to the Issuer's board of directors. Read SEC document |
| August 25, 2023 Filed Apr 3, 2024 16:44 UTC |
ROSENTHALER ALBERT EChief Corp. Dev. Officer
|
SaleSeries A Common Stock | 95 | $0.72 | $68.53 |
DisclosureSEC source: 0001225208-24-004898 · doc4.xml · nonDerivative · entry 1 ROSENTHALER ALBERT E · CIK 0001195195 · Chief Corp. Dev. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,746 F1 · kind: The sale reported on this Form 4 was the result of an error by the reporting person's broker in connection with the vesting and settlement of shares of Series A Common Stock pursuant to a performance-based restricted stock unit granted on March 10, 2022. The transaction reported does not represent a discretionary transaction by the reporting person. F2 · balance_after: The total number of shares reported as benefically owned reflects the total beneficially owned by the reporting person as of August 25, 2023. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 21:56 UTC |
MAFFEI GREGORY BDirector · Chairman of the Board · 10% owner
|
Sale8% Series A Cumulative Redeemable Preferred Stock | 101 | $35.63 | $3,598.60 |
DisclosureSEC source: 0001225208-23-008356 · doc4.xml · nonDerivative · entry 1 MAFFEI GREGORY B · CIK 0001099636 · Director · Chairman of the Board · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Sheila Q Maffei 2010 Trust Disclosed balance after: 0 F1 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $35.60 to $35.63, inclusive. The reporting person undertakes to provide to the Securities and ExchangeCommission, the Issuer, or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: The Reporting Person is the successor trustee of the Sheila Q Maffei 2010 Trust, which trust is for the benefit of the estate of Ms. Sheila Maffei. The reporting person disclaims any pecuniary interest in the shares held by the Sheila Q Maffei 2010 Trust. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 20:29 UTC |
DIAS FIONA PDirector
|
GrantDividend Equivalent Rights - QRTEA · Derivative | 586 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-006929 · doc4.xml · derivative · entry 1 DIAS FIONA P · CIK 0001209881 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,780 Underlying: Series A Common Stock · 586 shares Expires not disclosed F1 · derivative.exercise_price: On May 17, 2023, the Issuer announced that an authorized committee of its board of directors declared a quarterly cash dividend in the amount of $2.00 per share of its 8.0% Series A Cumulative Redeemable Preferred Stock ("Preferred Stock") payable on June 15, 2023 to stockholders of record of the Preferred Stock at the close of business on May 31, 2023 (the "Dividend"). The equivalent rights accrued on restricted stock units with respect to the Issuer's Preferred Stock ("Original RSUs") held by the reporting person as a result of the Dividend and are subject to the same terms and conditions (including vesting and expiration) as the Original RSUs to which they relate. Each dividend equivalent right entitles the reporting person to receive one share of the Issuer's Series A Common Stock. The grant of dividend equivalent rights was approved by the Issuer's board of directors pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: Each dividend equivalent right vests upon the reporting person's termination of service to the Issuer's board of directors. F3 · derivative.expiration_date: Each dividend equivalent right expires upon the reporting person's termination of service to the Issuer's board of directors. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 16:44 UTC |
ROSENTHALER ALBERT EChief Corp. Dev. Officer
|
SaleSeries A Common Stock | 18,100 | $0.92 | $16,704.49 |
DisclosureSEC source: 0001225208-23-004169 · doc4.xml · nonDerivative · entry 1 ROSENTHALER ALBERT E · CIK 0001195195 · Chief Corp. Dev. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,841 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of shares of Series A Common Stock pursuant to a performance-based restricted stock unit granted on March 10, 2022. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. F2 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $0.8849 to $0.9868, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: The Issuer has eliminated Series A Common Stock as an investment alternative available under the Liberty Media 401(k) Savings Plan (the "Plan"). Subsequently, in March 2023, the 35,604 shares of Series A Common Stock the reporting person beneficially owned under the Plan were liquidated. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:45 UTC |
Wilm Renee LChief Legal/Admin Officer
|
SaleSeries A Common Stock | 18,100 | $0.92 | $16,708.11 |
DisclosureSEC source: 0001225208-23-004171 · doc4.xml · nonDerivative · entry 1 Wilm Renee L · CIK 0001789667 · Chief Legal/Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,166 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of shares of Series A Common Stock pursuant to a performance-based restricted stock unit granted on March 10, 2022. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. F2 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $0.8833 to $0.9915, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:44 UTC |
Rawlinson DavidDirector · President/CEO
|
SaleSeries A Common Stock | 89,300 | $0.92 | $82,406.04 |
DisclosureSEC source: 0001225208-23-004168 · doc4.xml · nonDerivative · entry 1 Rawlinson David · CIK 0001698247 · Director · President/CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372,004 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of shares of Series A Common Stock pursuant to a performance-based restricted stock unit granted on March 10, 2022. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. F2 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $0.8800 to $0.9957, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:45 UTC |
Wendling Brian JCAO/PFO
|
SaleSeries A Common Stock | 10,100 | $0.92 | $9,327.35 |
DisclosureSEC source: 0001225208-23-004170 · doc4.xml · nonDerivative · entry 1 Wendling Brian J · CIK 0001663090 · CAO/PFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,231 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of shares of Series A Common Stock pursuant to a performance-based restricted stock unit granted on March 10, 2022. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. F2 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $0.8853 to $0.9858, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:58 UTC |
DIAS FIONA PDirector
|
GrantDividend Equivalent Rights - QRTEA · Derivative | 498 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004102 · doc4.xml · derivative · entry 1 DIAS FIONA P · CIK 0001209881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,194 Underlying: Series A Common Stock · 498 shares Expires not disclosed F1 · derivative.exercise_price: On February 16, 2023, the Issuer announced that an authorized committee of its board of directors declared a quarterly cash dividend in the amount of $2.00 per share of its 8.0% Series A Cumulative Redeemable Preferred Stock ("Preferred Stock") payable on March 15, 2023 to stockholders of record of the Preferred Stock at the close of business on February 28, 2023 (the "Dividend"). The equivalent rights accrued on restricted stock units with respect to the Issuer's Preferred Stock ("Original RSUs") held by the reporting person as a result of the Dividend and are subject to the same terms and conditions (including vesting and expiration) as the Original RSUs to which they relate. Each dividend equivalent right entitles the reporting person to receive one share of the Issuer's Series A Common Stock. The grant of dividend equivalent rights was approved by the Issuer's board of directors pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: Each dividend equivalent right vests upon the reporting person's termination of service to the Issuer's board of directors. F3 · derivative.expiration_date: Each dividend equivalent right expires upon the reporting person's termination of service to the Issuer's board of directors. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 22:13 UTC |
MAFFEI GREGORY BDirector · Chairman of the Board · 10% owner
|
GrantSeries B Common Stock | 326,868 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-003542 · doc4.xml · nonDerivative · entry 1 MAFFEI GREGORY B · CIK 0001099636 · Director · Chairman of the Board · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,711,446 F1 · security: Each share of Series B Common Stock is convertible, at the holder's election, into one share of Series A Common Stock, at any time for no consideration other than the surrender of the share of Series B Common Stock for each share of Series A Common Stock. F2 · shares: Represents shares of Series B Common Stock to be issued as a result of the certification on March 3, 2023 of the satisfaction of performance criteria established for the performance-based restricted stock units granted to the reporting person on March 10, 2022. This grant was made pursuant to the employment agreement between the reporting person and Liberty Media Corporation effective December 13, 2019 (the "Agreement"). This grant was a portion of the reporting person's Annual Equity Awards (as defined in the Agreement). Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 17:13 UTC |
ROSENTHALER ALBERT EChief Corp. Dev. Officer
|
GrantSeries A Common Stock | 30,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-003543 · doc4.xml · nonDerivative · entry 1 ROSENTHALER ALBERT E · CIK 0001195195 · Chief Corp. Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,941 F1 · shares: Represents shares of Series A Common Stock to be issued as a result of the certification on March 3, 2023 of the satisfaction of performance criteria established for the performance-based restricted stock units granted to the reporting person on March 10, 2022. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 22:13 UTC |
Wilm Renee LChief Legal/Admin Officer
|
GrantSeries A Common Stock | 30,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-003546 · doc4.xml · nonDerivative · entry 1 Wilm Renee L · CIK 0001789667 · Chief Legal/Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,266 F1 · shares: Represents shares of Series A Common Stock to be issued as a result of the certification on March 3, 2023 of the satisfaction of performance criteria established for the performance-based restricted stock units granted to the reporting person on March 10, 2022. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 22:13 UTC |
Rawlinson DavidDirector · President/CEO
|
GrantSeries A Common Stock | 238,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-003544 · doc4.xml · nonDerivative · entry 1 Rawlinson David · CIK 0001698247 · Director · President/CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 461,304 F1 · shares: Represents shares of Series A Common Stock to be issued as a result of the certification on March 3, 2023 of the satisfaction of performance criteria established for the performance-based restricted stock units granted to the reporting person on March 10, 2022. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 22:13 UTC |
Wendling Brian JCAO/PFO
|
GrantSeries A Common Stock | 16,747 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-003545 · doc4.xml · nonDerivative · entry 1 Wendling Brian J · CIK 0001663090 · CAO/PFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,331 F1 · shares: Represents shares of Series A Common Stock to be issued as a result of the certification on March 3, 2023 of the satisfaction of performance criteria established for the performance-based restricted stock units granted to the reporting person on March 10, 2022. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:35 UTC |
DIAS FIONA PDirector
|
GrantDividend Equivalent Rights - QRTEA · Derivative | 280 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012879 · doc4.xml · derivative · entry 1 DIAS FIONA P · CIK 0001209881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,696 Underlying: Series A Common Stock · 280 shares Expires not disclosed F1 · derivative.exercise_price: On November 14, 2022, the Issuer announced that an authorized committee of its board of directors declared a quarterly cash dividend in the amount of $2.00 per share of its 8.0% Series A Cumulative Redeemable Preferred Stock ("Preferred Stock") payable on December 15, 2022 to stockholders of record of the Preferred Stock at the close of business on November 30, 2022 (the "Dividend"). The equivalent rights accrued on restricted stock units with respect to the Issuer's Preferred Stock ("Original RSUs") held by the reporting person as a result of the Dividend and are subject to the same terms and conditions (including vesting and expiration) as the Original RSUs to which they relate. Each dividend equivalent right entitles the reporting person to receive one share of the Issuer's Series A Common Stock. The grant of dividend equivalent rights was approved by the Issuer's board of directors pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: Each dividend equivalent right vests upon the reporting person's termination of service to the Issuer's board of directors. F3 · derivative.expiration_date: Each dividend equivalent right expires upon the reporting person's termination of service to the Issuer's board of directors. Read SEC document |
| December 10, 2022 Filed Dec 13, 2022 23:57 UTC |
Rawlinson DavidDirector · President/CEO
|
Exercise / conversionRestricted Stock Units - QRTEA · Derivative | 147,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012644 · doc4.xml · derivative · entry 3 Rawlinson David · CIK 0001698247 · Director · President/CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,142 Underlying: Series A Common Stock · 147,571 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock. F3 · derivative.exercise_date: This restricted stock unit award vested 13% on December 10, 2021 and 29% on December 10, 2022, and will vest 29% on each of December 10, 2023 and December 10, 2024. F3 · derivative.expiration_date: This restricted stock unit award vested 13% on December 10, 2021 and 29% on December 10, 2022, and will vest 29% on each of December 10, 2023 and December 10, 2024. Read SEC document |
| December 10, 2022 Filed Dec 13, 2022 23:57 UTC |
Rawlinson DavidDirector · President/CEO
|
Tax withholdingSeries A Common Stock | 64,164 | $1.98 | $127,044.72 |
DisclosureSEC source: 0001225208-22-012644 · doc4.xml · nonDerivative · entry 2 Rawlinson David · CIK 0001698247 · Director · President/CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,854 Read SEC document |
| December 10, 2022 Filed Dec 13, 2022 23:57 UTC |
Rawlinson DavidDirector · President/CEO
|
Exercise / conversionSeries A Common Stock | 147,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012644 · doc4.xml · nonDerivative · entry 1 Rawlinson David · CIK 0001698247 · Director · President/CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converted into one share of Series A Common Stock. Read SEC document |
| December 08, 2022 Filed Dec 12, 2022 21:39 UTC |
ROMRELL LARRY EDirector
|
GrantRestricted Stock Units - QRTEA · Derivative | 60,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012570 · doc4.xml · derivative · entry 1 ROMRELL LARRY E · CIK 0001120556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,558 Underlying: Series A Common Stock · 60,558 shares Expires 2023-12-08 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock. Read SEC document |
| December 08, 2022 Filed Dec 12, 2022 21:39 UTC |
Wong Andrea LDirector
|
GrantRestricted Stock Units - QRTEA · Derivative | 60,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012571 · doc4.xml · derivative · entry 1 Wong Andrea L · CIK 0001490754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,558 Underlying: Series A Common Stock · 60,558 shares Expires 2023-12-08 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock. Read SEC document |
| December 08, 2022 Filed Dec 12, 2022 21:38 UTC |
Gilchrist Malcolm Ian GrantDirector
|
GrantRestricted Stock Units - QRTEA · Derivative | 60,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012568 · doc4.xml · derivative · entry 1 Gilchrist Malcolm Ian Grant · CIK 0001469449 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,558 Underlying: Series A Common Stock · 60,558 shares Expires 2023-12-08 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock. Read SEC document |
| December 08, 2022 Filed Dec 12, 2022 21:38 UTC |
MALONE EVAN DANIELDirector
|
GrantRestricted Stock Units - QRTEA · Derivative | 60,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012569 · doc4.xml · derivative · entry 1 MALONE EVAN DANIEL · CIK 0001442645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,558 Underlying: Series A Common Stock · 60,558 shares Expires 2023-12-08 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock. Read SEC document |
| December 08, 2022 Filed Dec 12, 2022 21:38 UTC |
DIAS FIONA PDirector
|
GrantRestricted Stock Units - QRTEA · Derivative | 60,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012567 · doc4.xml · derivative · entry 1 DIAS FIONA P · CIK 0001209881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,558 Underlying: Series A Common Stock · 60,558 shares Expires 2023-12-08 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock. Read SEC document |
| December 08, 2022 Filed Dec 12, 2022 21:38 UTC |
BARTON RICHARD NDirector
|
GrantRestricted Stock Units - QRTEA · Derivative | 60,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012566 · doc4.xml · derivative · entry 1 BARTON RICHARD N · CIK 0001184230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,558 Underlying: Series A Common Stock · 60,558 shares Expires 2023-12-08 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock. Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 21:18 UTC |
ROMRELL LARRY EDirector
|
Exercise / conversionRestricted Stock Units - QRTEA · Derivative | 14,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012440 · doc4.xml · derivative · entry 2 ROMRELL LARRY E · CIK 0001120556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Series A Common Stock · 14,188 shares Expires 2022-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock. Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 21:18 UTC |
ROMRELL LARRY EDirector
|
Exercise / conversionSeries A Common Stock | 14,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012440 · doc4.xml · nonDerivative · entry 1 ROMRELL LARRY E · CIK 0001120556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converted into one share of Series A Common Stock. Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 21:18 UTC |
Wong Andrea LDirector
|
Exercise / conversionRestricted Stock Units - QRTEA · Derivative | 14,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012439 · doc4.xml · derivative · entry 2 Wong Andrea L · CIK 0001490754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Series A Common Stock · 14,188 shares Expires 2022-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock. Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 21:18 UTC |
Wong Andrea LDirector
|
Exercise / conversionSeries A Common Stock | 14,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012439 · doc4.xml · nonDerivative · entry 1 Wong Andrea L · CIK 0001490754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converted into one share of Series A Common Stock. Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 21:18 UTC |
Gilchrist Malcolm Ian GrantDirector
|
Exercise / conversionRestricted Stock Units - QRTEA · Derivative | 14,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012442 · doc4.xml · derivative · entry 2 Gilchrist Malcolm Ian Grant · CIK 0001469449 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Series A Common Stock · 14,188 shares Expires 2022-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock. Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 21:18 UTC |
Gilchrist Malcolm Ian GrantDirector
|
Exercise / conversionSeries A Common Stock | 14,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012442 · doc4.xml · nonDerivative · entry 1 Gilchrist Malcolm Ian Grant · CIK 0001469449 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converted into one share of Series A Common Stock. Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 21:19 UTC |
MALONE EVAN DANIELDirector
|
Exercise / conversionRestricted Stock Units - QRTEA · Derivative | 14,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012441 · doc4.xml · derivative · entry 2 MALONE EVAN DANIEL · CIK 0001442645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Series A Common Stock · 14,188 shares Expires 2022-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock. Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 21:19 UTC |
MALONE EVAN DANIELDirector
|
Exercise / conversionSeries A Common Stock | 14,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012441 · doc4.xml · nonDerivative · entry 1 MALONE EVAN DANIEL · CIK 0001442645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converted into one share of Series A Common Stock. Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 21:19 UTC |
DIAS FIONA PDirector
|
Exercise / conversionRestricted Stock Units - QRTEA · Derivative | 14,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012443 · doc4.xml · derivative · entry 2 DIAS FIONA P · CIK 0001209881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Series A Common Stock · 14,188 shares Expires 2022-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock. Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 21:19 UTC |
DIAS FIONA PDirector
|
Exercise / conversionSeries A Common Stock | 14,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012443 · doc4.xml · nonDerivative · entry 1 DIAS FIONA P · CIK 0001209881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,316 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converted into one share of Series A Common Stock. Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 21:19 UTC |
BARTON RICHARD NDirector
|
Exercise / conversionRestricted Stock Units - QRTEA · Derivative | 14,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012444 · doc4.xml · derivative · entry 3 BARTON RICHARD N · CIK 0001184230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Series A Common Stock · 14,188 shares Expires 2022-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock. Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 21:19 UTC |
BARTON RICHARD NDirector
|
Exercise / conversionSeries A Common Stock | 14,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012444 · doc4.xml · nonDerivative · entry 1 BARTON RICHARD N · CIK 0001184230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,791 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converted into one share of Series A Common Stock. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 22:09 UTC |
DIAS FIONA PDirector
|
GrantDividend Equivalent Rights - QRTEA · Derivative | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010395 · doc4.xml · derivative · entry 1 DIAS FIONA P · CIK 0001209881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,416 Underlying: Series A Common Stock · 200 shares Expires not disclosed F1 · derivative.exercise_price: On August 15, 2022, the Issuer announced that an authorized committee of its board of directors declared a quarterly cash dividend in the amount of $2.00 per share of its 8.0% Series A Cumulative Redeemable Preferred Stock ("Preferred Stock") payable on September 15, 2022 to stockholders of record of the Preferred Stock at the close of business on August 31, 2022 (the "Dividend"). The equivalent rights accrued on restricted stock units with respect to the Issuer's Preferred Stock ("Original RSUs") held by the reporting person as a result of the Dividend and are subject to the same terms and conditions (including vesting and expiration) as the Original RSUs to which they relate. Each dividend equivalent right entitles the reporting person to receive one share of the Issuer's Series A Common Stock. The grant of dividend equivalent rights was approved by the Issuer's board of directors pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: Each dividend equivalent right vests upon the reporting person's termination of service to the Issuer's board of directors. F3 · derivative.expiration_date: Each dividend equivalent right expires upon the reporting person's termination of service to the Issuer's board of directors. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 20:20 UTC |
Wendling Brian JCAO/PFO
|
SaleSeries A Common Stock | 15,732 | $3.17 | $49,875.16 |
DisclosureSEC source: 0001225208-22-009865 · doc4.xml · nonDerivative · entry 2 Wendling Brian J · CIK 0001663090 · CAO/PFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,584 F2 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $3.150 to $3.215, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 29, 2022 Filed Aug 31, 2022 20:20 UTC |
Wendling Brian JCAO/PFO
|
SaleSeries A Common Stock | 9,268 | $3.20 | $29,662.23 |
DisclosureSEC source: 0001225208-22-009865 · doc4.xml · nonDerivative · entry 1 Wendling Brian J · CIK 0001663090 · CAO/PFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,316 F1 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $3.200 to $3.205, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 20:40 UTC |
DIAS FIONA PDirector
|
GrantDividend Equivalent Rights - QRTEA · Derivative | 154 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008167 · doc4.xml · derivative · entry 1 DIAS FIONA P · CIK 0001209881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,216 Underlying: Series A Common Stock · 154 shares Expires not disclosed F1 · derivative.exercise_price: On May 18, 2022, the Issuer announced that an authorized committee of its board of directors declared a quarterly cash dividend in the amount of $2.00 per share of its 8.0% Series A Cumulative Redeemable Preferred Stock ("Preferred Stock") payable on June 15, 2022 to stockholders of record of the Preferred Stock at the close of business on May 31, 2022 (the "Dividend"). The equivalent rights accrued on restricted stock units with respect to the Issuer's Preferred Stock ("Original RSUs") held by the reporting person as a result of the Dividend and are subject to the same terms and conditions (including vesting and expiration) as the Original RSUs to which they relate. Each dividend equivalent right entitles the reporting person to receive one share of the Issuer's Series A Common Stock. The grant of dividend equivalent rights was approved by the Issuer's board of directors pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: Each dividend equivalent right vests upon the reporting person's termination of service to the Issuer's board of directors. F3 · derivative.expiration_date: Each dividend equivalent right expires upon the reporting person's termination of service to the Issuer's board of directors. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 21:56 UTC |
MAFFEI GREGORY BDirector · Chairman of the Board · 10% owner
|
Exercise / conversionExchange Right (Right to Buy) - QRTEB · Derivative | 229,022 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-22-005204 · doc4.xml · derivative · entry 4 MAFFEI GREGORY B · CIK 0001099636 · Director · Chairman of the Board · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Series B Common Stock · 229,022 shares Expires 2022-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On June 3, 2021, the Issuer and the reporting person entered into a Stock Exchange Agreement (the "Exchange Agreement"), as previously described in the Issuer's Current Report on Form 8-K filed on June 4, 2021, pursuant to which among other things, the Issuer agreed that on the terms and subject to the conditions of the Exchange Agreement, the reporting person at his option, during the six-month period following the vesting of the performance-based restricted stock unit award (the "PRSU award") granted to the reporting person on March 10, 2021, may transfer to the Issuer the number of shares of Series A Common Stock received by the reporting person upon vesting of such PRSU award in exchange for an equivalent number of newly-issued shares of Series B Common Stock (the "Exchange Right"). The Exchange Agreement, Exchange Right and related exchanges were approved by a committee of the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended. F1 · price: On June 3, 2021, the Issuer and the reporting person entered into a Stock Exchange Agreement (the "Exchange Agreement"), as previously described in the Issuer's Current Report on Form 8-K filed on June 4, 2021, pursuant to which among other things, the Issuer agreed that on the terms and subject to the conditions of the Exchange Agreement, the reporting person at his option, during the six-month period following the vesting of the performance-based restricted stock unit award (the "PRSU award") granted to the reporting person on March 10, 2021, may transfer to the Issuer the number of shares of Series A Common Stock received by the reporting person upon vesting of such PRSU award in exchange for an equivalent number of newly-issued shares of Series B Common Stock (the "Exchange Right"). The Exchange Agreement, Exchange Right and related exchanges were approved by a committee of the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 21:56 UTC |
MAFFEI GREGORY BDirector · Chairman of the Board · 10% owner
|
Exercise / conversionSeries B Common Stock | 229,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-005204 · doc4.xml · nonDerivative · entry 2 MAFFEI GREGORY B · CIK 0001099636 · Director · Chairman of the Board · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,384,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each share of Series B Common Stock is convertible, at the holder's election, into one share of Series A Common Stock, at any time for no consideration other than the surrender of the share of Series B Common Stock for each share of Series A Common Stock. F1 · price: On June 3, 2021, the Issuer and the reporting person entered into a Stock Exchange Agreement (the "Exchange Agreement"), as previously described in the Issuer's Current Report on Form 8-K filed on June 4, 2021, pursuant to which among other things, the Issuer agreed that on the terms and subject to the conditions of the Exchange Agreement, the reporting person at his option, during the six-month period following the vesting of the performance-based restricted stock unit award (the "PRSU award") granted to the reporting person on March 10, 2021, may transfer to the Issuer the number of shares of Series A Common Stock received by the reporting person upon vesting of such PRSU award in exchange for an equivalent number of newly-issued shares of Series B Common Stock (the "Exchange Right"). The Exchange Agreement, Exchange Right and related exchanges were approved by a committee of the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 21:56 UTC |
MAFFEI GREGORY BDirector · Chairman of the Board · 10% owner
|
Disposition to issuerSeries A Common Stock | 229,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-005204 · doc4.xml · nonDerivative · entry 1 MAFFEI GREGORY B · CIK 0001099636 · Director · Chairman of the Board · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: On June 3, 2021, the Issuer and the reporting person entered into a Stock Exchange Agreement (the "Exchange Agreement"), as previously described in the Issuer's Current Report on Form 8-K filed on June 4, 2021, pursuant to which among other things, the Issuer agreed that on the terms and subject to the conditions of the Exchange Agreement, the reporting person at his option, during the six-month period following the vesting of the performance-based restricted stock unit award (the "PRSU award") granted to the reporting person on March 10, 2021, may transfer to the Issuer the number of shares of Series A Common Stock received by the reporting person upon vesting of such PRSU award in exchange for an equivalent number of newly-issued shares of Series B Common Stock (the "Exchange Right"). The Exchange Agreement, Exchange Right and related exchanges were approved by a committee of the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:25 UTC |
DIAS FIONA PDirector
|
GrantDividend Equivalent Rights - QRTEA · Derivative | 108 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-004857 · doc4.xml · derivative · entry 1 DIAS FIONA P · CIK 0001209881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,062 Underlying: Series A Common Stock · 108 shares Expires not disclosed F1 · derivative.exercise_price: On February 16, 2022, the Issuer announced that its board of directors declared a quarterly cash dividend in the amount of $2.00 per share of its 8.0% Series A Cumulative Redeemable Preferred Stock ("Preferred Stock") payable on March 15, 2022 to stockholders of record of the Preferred Stock at the close of busines on February 28, 2022 (the "Dividend"). The equivalent rights accrued on restricted stock units with respect to the Issuer's Preferred Stock "Original RSUs") held by the reporting person as a result of the Dividend and are subject to the same terms and conditions (including vesting and expiration) as the Original RSUs to which they relate. Each dividend equivalent right entitles the reporting person to receive one share of the Issuer's Series A Common Stock. The grant of dividend equivalent rights was approved by the Issuer's board of directors pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: Each dividend equivalent right vests upon the reporting person's termination of service to the Issuer's board of directors. F3 · derivative.expiration_date: Each dividend equivalent right expires upon the reporting person's termination of service to the Issuer's board of directors. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 16:25 UTC |
ROSENTHALER ALBERT EChief Corp. Dev. Officer
|
Tax withholdingSeries A Common Stock | 8,750 | $4.84 | $42,350.00 |
DisclosureSEC source: 0001225208-22-004856 · doc4.xml · nonDerivative · entry 1 ROSENTHALER ALBERT E · CIK 0001195195 · Chief Corp. Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,688 Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:25 UTC |
Wendling Brian JCAO/PFO
|
Tax withholdingSeries A Common Stock | 4,844 | $4.84 | $23,444.96 |
DisclosureSEC source: 0001225208-22-004855 · doc4.xml · nonDerivative · entry 1 Wendling Brian J · CIK 0001663090 · CAO/PFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,584 Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:24 UTC |
Rawlinson DavidDirector · President/CEO
|
Tax withholdingSeries A Common Stock | 40,641 | $4.84 | $196,702.44 |
DisclosureSEC source: 0001225208-22-004854 · doc4.xml · nonDerivative · entry 1 Rawlinson David · CIK 0001698247 · Director · President/CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,447 Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:24 UTC |
Wilm Renee LChief Legal/Admin Officer
|
Tax withholdingSeries A Common Stock | 8,750 | $4.84 | $42,350.00 |
DisclosureSEC source: 0001225208-22-004853 · doc4.xml · nonDerivative · entry 1 Wilm Renee L · CIK 0001789667 · Chief Legal/Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,013 Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:32 UTC |
MAFFEI GREGORY BDirector · Chairman of the Board · 10% owner
|
GrantExchange Right (Right to Buy) - QRTEB · Derivative | 229,022 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-22-004634 · doc4.xml · derivative · entry 3 MAFFEI GREGORY B · CIK 0001099636 · Director · Chairman of the Board · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,022 Underlying: Series B Common Stock · 229,022 shares Expires 2022-09-15 F3 · derivative.exercise_price: On June 3, 2021, the Issuer and the reporting person entered into a Stock Exchange Agreement (the "Exchange Agreement"), as previously described in the Issuer's Current Report on Form 8-K filed on June 4, 2021, pursuant to which among other things, the Issuer agreed that on the terms and subject to the conditions of the Exchange Agreement, the reporting person, at his option during the six-month period following the vesting of the performance-based restricted stock unit award (the "PRSU award") granted to the reporting person on March 10, 2021, may transfer to the Issuer the number of shares of Series A Common Stock received by the reporting person upon vesting of such PRSU award in exchange for an equivalent number of newly-issued shares of Series B Common Stock (the "Exchange Right"). The Exchange Agreement, Exchange Right and related exchanges were approved by a committee of the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended. F3 · price: On June 3, 2021, the Issuer and the reporting person entered into a Stock Exchange Agreement (the "Exchange Agreement"), as previously described in the Issuer's Current Report on Form 8-K filed on June 4, 2021, pursuant to which among other things, the Issuer agreed that on the terms and subject to the conditions of the Exchange Agreement, the reporting person, at his option during the six-month period following the vesting of the performance-based restricted stock unit award (the "PRSU award") granted to the reporting person on March 10, 2021, may transfer to the Issuer the number of shares of Series A Common Stock received by the reporting person upon vesting of such PRSU award in exchange for an equivalent number of newly-issued shares of Series B Common Stock (the "Exchange Right"). The Exchange Agreement, Exchange Right and related exchanges were approved by a committee of the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:32 UTC |
MAFFEI GREGORY BDirector · Chairman of the Board · 10% owner
|
GrantSeries A Common Stock | 229,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-004634 · doc4.xml · nonDerivative · entry 1 MAFFEI GREGORY B · CIK 0001099636 · Director · Chairman of the Board · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,022 F1 · shares: Represents shares of Series A Common Stock to be issued as a result of the certification on March 10, 2022 of the satisfaction of performance criteria established for the performance-based restricted stock units granted to the reporting person on March 10, 2021. This grant was made pursuant to the employment agreement between the reporting person and Liberty Media Corporation effective December 13, 2019 (the "Agreement"). This grant was a portion of the reporting person's Annual Equity Awards (as defined in the Agreement). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.